Study identifies rapidly dividing cancer stem cells that can respond to new therapies
Brain cancers have long been thought of as being resistant to treatments because of the presence of multiple types of cancer cells within each tumor. A new study uncovers a cancer cell hierarchy that originates from a single cancer cell type, which can be targeted to slow cancer growth.
$109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease
By Gillian Woodford
Nine McGill University-led projects are among the 139 selected for funding through the Canadian Institutes of Health Research (CIHR)’s COVID-19 Rapid Research Funding Opportunity, announced on June 25, 2020. The McGill-led projects will receive over $3.5M in total funding.
As COVID-19 restrictions loosen this summer, Canadians will spend more time outdoors and make the most of the sunshine. A new study from McGill University suggests why men may be more genetically prone to develop skin cancer.
Smoking is the best-known risk factor for chronic obstructive pulmonary disease (COPD), a debilitating lung condition that can severely limit a person’s day-to-day activities. But curiously, only a minority of lifelong smokers develops the disease, while non-smokers represent more than 25% of all COPD cases.
Never before have we experienced social isolation on a massive scale as we have during the evolving COVID-19 pandemic. A new paper published in the journal Trends in Cognitive Sciences explores the wide-ranging, negative consequences that social isolation has on our psychological well-being and physical health, including decreased life span.
C. L. de Carvalho-Heineken Prize recognizes his seminal work in the cognition of music
Cognitive neuroscientist Robert Zatorre has been awarded the C.L. de Carvalho-Heineken Prize in Cognitive Sciences.
Award recognizes his collaborative work in neuroscience and neuroinformatics
Neuroscientist Alan Evans has been awarded the Killam Prize, one of Canada’s highest honours, for his numerous contributions to the understanding of the human brain.
Evans is an internationally recognized researcher at The Neuro (Montreal Neurological Institute-Hospital), James McGill Professor in Neurology and Neurosurgery and the Victor Dahdaleh Chair in Neurosciences.
McGill-Gothenburg collaboration yields affordable test that could revolutionize the way AD is diagnosed, studied and treated
By Gillian Woodford
These return of service bursaries are coordinated locally by the English-speaking community networks serving the Montreal Metropolitan Communities. The bursaries are designed to respond to specific priorities for access to health and social services in the English language in the Greater Montreal Region. These needs are identified by community networks and health and social service institutions in their catchment area.
Nancy Ross, McGill’s Associate Vice-Principal, Research and Innovation, recently announced the appointment, effective April 1, 2020, of Dr. Carmen Loiselle as Dialogue McGill’s new Principal Investigator.
Under the leadership of the English-speaking community networks from the selected Quebec regions these return of service bursaries are designed to respond to regional and local needs for access to services in English.
COVID-19: Faculty of Medicine Update 2020/04/05 - Message from VP-Dean Eidelman - Faculty Council Takeaways and FAQs
To all members of the Faculty of Medicine, including learners and staff,
Montreal medical specialists and 3D printing company team up to find solutions for critical supply shortages
The COVID-19 pandemic has created an unprecedented need to provide personal protective equipment (PPE) for hospital staff. A team of Montreal medical experts has partnered with a 3D printing company to design and distribute face shields to protect healthcare workers as they treat patients with this life-threatening disease.
The Neuro’s director has been a driving force in neurological disease research and Open Science leadership
There has been a lot of recent interest in the use of psychedelic drugs to treat depression. A new study from McGill suggests that, in the right context, some people may experience psychedelic-like effects from placebos alone. The researchers reported some of the strongest placebo effects (these are effects from “fake” medication) on consciousness in the literature relating to psychedelic drugs.